Up a level |
2020
Volz, Caroline, Breid, Sara, Selenz, Carolin, Zaplatina, Alina, Golfmann, Kristina, Meder, Lydia, Dietlein, Felix, Borchmann, Sven, Chatterjee, Sampurna, Siobal, Maike, Schoettle, Jakob, Florin, Alexandra, Koker, Mirjam, Nill, Marieke, Ozretic, Luka, Uhlenbrock, Niklas, Smith, Steven, Buettner, Reinhard, Miao, Hui, Wang, Bingcheng, Reinhardt, H. Christian, Rauh, Daniel, Hallek, Michael, Acker-Palmer, Amparo, Heukamp, Lukas C. and Ullrich, Roland T. (2020). Inhibition of Tumor VEGFR2 Induces Serine 897 EphA2-Dependent Tumor Cell Invasion and Metastasis in NSCLC. Cell Reports, 31 (4). CAMBRIDGE: CELL PRESS. ISSN 2211-1247
2018
Golfmann, Kristina, Meder, Lydia ORCID: 0000-0002-9547-5812, Koker, Mirjam, Volz, Caroline, Borchmann, Sven, Tharun, Lars, Dietlein, Felix, Malchers, Florian, Florin, Alexandra, Buettner, Reinhard, Rosen, Neal, Rodrik-Outmezguine, Vanessa, Hallek, Michael and Ullrich, Roland T. (2018). Synergistic anti-angiogenic treatment effects by dual FGFR1 and VEGFR1 inhibition in FGFR1-amplified breast cancer. Oncogene, 37 (42). S. 5682 - 5694. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5594
2016
Volz, Caroline (2016). The role of VEGFR2 and EphA2 in tumor cell invasion in non-small-cell lung cancer. Thesis Abstract, Universität zu Köln.
2015
Schoettle, Jakob, Chatterjee, Sampurna, Volz, Caroline, Siobal, Maike, Florin, Alexandra, Rokitta, Dennis, Hinze, Yvonne, Dietlein, Felix, Plenker, Dennis, Koenig, Katharina, Albus, Kerstin, Heuckmann, Johannes M., Rauh, Daniel ORCID: 0000-0002-1970-7642, Franz, Thomas, Neumaier, Bernd ORCID: 0000-0001-5425-3116, Fuhr, Uwe, Heukamp, Lukas C. and Ullrich, Roland T. (2015). Intermittent high-dose treatment with erlotinib enhances therapeutic efficacy in EGFR-mutant lung cancer. Oncotarget, 6 (36). S. 38458 - 38469. ORCHARD PARK: IMPACT JOURNALS LLC. ISSN 1949-2553